CLPT Valuation

Clearpoint Neuro Inc

Add to Watchlist

Advanced Chart

10.700

+0.46(4.492%)1D

Overview
Forecast
Valuation
Earnings

CLPT Relative Valuation

CLPT's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, CLPT is overvalued; if below, it's undervalued.

Historical Valuation

Clearpoint Neuro Inc (CLPT) is now in the Fair zone, suggesting that its current forward PS ratio of 6.78 is considered Fairly compared with the five-year average of -17.27. The fair price of Clearpoint Neuro Inc (CLPT) is between 9.05 to 24.72 according to relative valuation methord.

Relative Value

Fair Zone

9.05-24.72

Current Price：10.88

Fair

-14.54

Trailing

Forward

-23.17

EV/EBITDA

Clearpoint Neuro Inc. (CLPT) has a current EV/EBITDA of -23.17. The 5-year average EV/EBITDA is -22.49. The thresholds are as follows: Strongly Undervalued below -46.17, Undervalued between -46.17 and -34.33, Fairly Valued between -10.64 and -34.33, Overvalued between -10.64 and 1.20, and Strongly Overvalued above 1.20. The current Forward EV/EBITDA of -23.17 falls within the Historic Trend Line -Fairly Valued range.

-13.84

EV/EBIT

Clearpoint Neuro Inc. (CLPT) has a current EV/EBIT of -13.84. The 5-year average EV/EBIT is -15.72. The thresholds are as follows: Strongly Undervalued below -33.16, Undervalued between -33.16 and -24.44, Fairly Valued between -7.00 and -24.44, Overvalued between -7.00 and 1.72, and Strongly Overvalued above 1.72. The current Forward EV/EBIT of -13.84 falls within the Historic Trend Line -Fairly Valued range.

6.70

Clearpoint Neuro Inc. (CLPT) has a current PS of 6.70. The 5-year average PS is 11.19. The thresholds are as follows: Strongly Undervalued below -1.03, Undervalued between -1.03 and 5.08, Fairly Valued between 17.30 and 5.08, Overvalued between 17.30 and 23.40, and Strongly Overvalued above 23.40. The current Forward PS of 6.70 falls within the Historic Trend Line -Fairly Valued range.

-64.69

P/OCF

Clearpoint Neuro Inc. (CLPT) has a current P/OCF of -64.69. The 5-year average P/OCF is -18.92. The thresholds are as follows: Strongly Undervalued below -66.91, Undervalued between -66.91 and -42.91, Fairly Valued between 5.08 and -42.91, Overvalued between 5.08 and 29.08, and Strongly Overvalued above 29.08. The current Forward P/OCF of -64.69 falls within the Undervalued range.

-68.49

P/FCF

Clearpoint Neuro Inc. (CLPT) has a current P/FCF of -68.49. The 5-year average P/FCF is -29.59. The thresholds are as follows: Strongly Undervalued below -84.52, Undervalued between -84.52 and -57.06, Fairly Valued between -2.12 and -57.06, Overvalued between -2.12 and 25.35, and Strongly Overvalued above 25.35. The current Forward P/FCF of -68.49 falls within the Undervalued range.

Clearpoint Neuro Inc (CLPT) has a current Price-to-Book (P/B) ratio of 14.79. Compared to its 3-year average P/B ratio of 8.79 , the current P/B ratio is approximately 68.30% higher. Relative to its 5-year average P/B ratio of 63.98, the current P/B ratio is about -76.88% higher. Clearpoint Neuro Inc (CLPT) has a Forward Free Cash Flow (FCF) yield of approximately -3.97%. Compared to its 3-year average FCF yield of -6.78%, the current FCF yield is approximately -41.34% lower. Relative to its 5-year average FCF yield of -5.69% , the current FCF yield is about -30.15% lower.

15.80

P/B

Median3y

8.79

Median5y

63.98

-4.02

FCF Yield

Median3y

-6.78

Median5y

-5.69

Competitors Valuation Multiple

The average P/S ratio for CLPT's competitors is 7.48, providing a benchmark for relative valuation. Clearpoint Neuro Inc Corp (CLPT) exhibits a P/S ratio of , which is -100.00% above the industry average. Given its robust revenue growth of 17.27%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

Butterfly Network Inc

3.53

8.82%

382.65M

Performance Decomposition

Market capitalization of CLPT decreased by 17.57% over the past 1 year. The primary factor behind the change was an increase in Revenue Growth from 7.86M to 9.22M.

The secondary factor is the Margin Expansion, contributed 12.91%to the performance.

Overall, the performance of CLPT in the past 1 year is driven by Revenue Growth. Which is more sustainable.

17.27%

7.86M → 9.22M

Revenue Growth

12.91%

-56.10 → -63.34

Margin Expansion

-47.75%

-26.27 → -13.73

P/E Change

-17.57%